Senior Principal Scientist and Senior Director at Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (Early CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

2019-Present, co-PI for graduate student Oveis Jamialahmadi together with Prof. Stefano Romeo, Dept of Molecular and Clinical Medicine, Göteborg University, Sweden.2018-2022, co-PI for postdoc Kay Liu together with Dr. Alan Sabirsh, AZ and Prof. Anna Salvati, Dept of Nanomedicine & Drug Targeting, University of Groningen, The Netherlands.2016-2019, co-PI for postdoc Sebastian Prill together with Prof. Stefano Romeo, Dept of Molecular and Clinical Medicine, Göteborg University, Sweden. 2014-2016, Principal Investigator for postdoc Amy Warner together with Dr Patrick Seale at the School of Medicine, University of Pennsylvania.2007-2008, Principal Investigator for postdoc's Per-Arne Svensson and Anna Ljungberg together with Professor's Lena Carlsson and Jan Borén at the Sahlgrenska Center for Cardiovascular and Metabolic Research and Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Sweden. 2001-2006, Co-supervisor for graduate student Anna Ljungberg at Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Sweden. Thesis with the title: “The role of PPAR alpha on growth hormone in hepatic lipid metabolism and atherosclerosis” defended 8th June 2006.1997-2007, Supervisor/ co-supervisor for 10 graduate students.

Associate Director and Principal Scientist at the Bioscience Diabetes department. Department representative in joint disease and core research teams with Ionis Pharmaceuticals developing antisense therapies for diabetes and NASH.

Project Leader and Bioscience Leader for pre-clinical drug discovery projects in Diabetes and NASH.

Team leader at the department of Bioscience working with drug discovery projects in diabetes and obesity. Project leader for a monoclonal antibody project targeting FGFR1c aimed for the treatment of obesity. Principal investigator for research collaboration with Professor Hans-Rudolf Berthoud at Pennington Biomedical Research Center in Baton Rouge, USA. Bioscience leader for a small molecule project antagonizing MCHR1 delivering a clinical candidate drug for the treatment of obesity.

Principal investigator for collaboration with Professor Domenico Accili at Columbia University Medical Center in New York on a novel approach to treat diabetes.

Secondment for one year working with Dr. Anthony Ferrante on adipose tissue inflammation in relation to insulin sensitivity as part of a strategic alliance collaboration at Columbia University Medical Center in New York.

Team leader for different pharmacology teams at the department of Bioscience working with drug discovery projects in diabetes, obesity, dyslipidemia, and diabetic nephropathy.

Senior scientist working with dyslipidemia at the department of Integrative Pharmacology.

Postdoc working with obesity at the department of Integrative Pharmacology. Principal investigator; Professor Leonard Storlien.